Table 3.
Treatment | TBARS (nM/mg protein) | GSH (μM) | |
---|---|---|---|
Control | 1.25 ± 0.12a | 41.19 ± 1.14b | |
ZEN | 25 μM | 3.15 ± 0.46b | 36.54 ± 0.19a |
50 μM | 4.08 ± 0.45b | 21.48 ± 2.24c | |
100 μM | 5.21±0.52c | 15.37 ± 0.36c | |
150 μM | 5.62±0.62c | 13.64 ± 0.28c | |
200 μM | 7.37 ± 0.24d | 11.89 ± 1.75cd | |
NACA 10mM | 1.37 ± 0.29a | 45.24 ± 1.34a | |
ZEN + NACA | 25 μM+ 10mM | 2.03 ± 0.34b | 40.16 ± 1.36b |
50 μM+ 10mM | 2.18 ± 0.16b | 36.49 ± 0.37b | |
100 μM+ 10mM | 2.09 ± 0.62b | 38.32 ± 0.21c | |
150 μM+ 10mM | 4.26 ± 0.36c | 32.58 ± 1.32d | |
200 μM+ 10mM | 5.18 ± 0.47d | 30.75 ± 1.54d |
abcd Mean ± SD with different superscripts in the same row are significantly different (p < 0.01).